Ramucirumab(Cyramza) is an important therapeutic agent. This article will introduce its indications, dosage, side effects and precautions in detail to help patients better understand and use the drug.
Detailed instructions for Ramucirumab: indications, dosage, side effects and precautions
Ramucirumab has been marketed in China, but has not yet entered the Chinese National Medical Insurance Catalogue. There are currently no generic versions of the drug on the market. Eli Lilly exported the Turkish version of the original drug, with a specification of 100mg*2 pieces.
Since Ramucirumab is not covered by medical insurance, patients are responsible for the full cost of their own expenses. It is recommended that patients choose formal channels when purchasing to ensure the quality of medicines.
Indications
Ramucirumab is mainly used to treat adult patients with specific diseases such as some gastric diseases and lung diseases. The specific indications need to be judged by the doctor according to the specific situation of the patient, and the use should be used according to the doctor's instructions.
Before taking Ramucirumab, patients should undergo adequate testing to ensure that they are eligible. At the same time, during the treatment process, we should pay close attention to the changes in the condition and adjust the treatment plan in time.
Usage and dosage
The recommended dose of Ramucirumab is 8mg/kg every 2weeks by intravenous infusion over a 60-minute infusion period. If the first infusion is tolerated, all subsequent infusions can be administered within 30minutes.
When patients use Ramucirumab, they should use it strictly according to the dosage and usage prescribed by the doctor, and should not change it at will. At the same time, changes in the condition and adverse drug reactions should be monitored regularly, and the treatment plan should be adjusted in time.
Side effects and precautions
Ramucirumab may have some side effects during use, such as hypertension, arterial thromboembolic events (including myocardial infarction, cardiac arrest, etc.). Patients should pay close attention to their own conditions during use, and seek medical attention in time if they feel unwell.
Special attention should be paid to the use of drugs in special populations
Ramucirumab should be avoided in pregnant women because of the potential for fetal harm; Breastfeeding should be avoided during the drug and for 2 months after discontinuation; Women and men of reproductive potential should consult their doctor before use to understand the effects of the drug on fertility.
During the use of Ramucirumab, patients should maintain good lifestyle habits and avoid overwork and mood swings, so as not to affect the efficacy of the drug. At the same time, regular follow-up visits should be made so that doctors can keep abreast of changes in the condition and adjust the treatment plan.
